- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 12, 2023
Discovery & Translation
Lurie winners show mitochondria is more than a powerhouse
Northwestern’s Navdeep Chandel and Harvard’s Vamsi Mootha share the FNIH’s 2023 prize for pioneering mitochondrial biology beyond ATP
BioCentury | Dec 14, 2022
Emerging Company Profile
Lucy: mitochondrial solutions to CNS diseases
Company’s first indications are Parkinson’s disease, Rett syndrome
BioCentury | Jun 2, 2022
Distillery Therapeutics
Targeting CYLD to promote neuron survival in Parkinson's
BioCentury | May 9, 2020
Translation in Brief
Antigens for COVID-19 serological testing; plus mapping glycans on SARS-CoV-2 spike, tumor sampling method and therapy for Parkinson’s
BioCentury’s roundup of preclinical news
BioCentury | Jul 26, 2019
Translation in Brief
GI infection as Parkinson’s trigger
McGill, UMontreal team describe chain of events leading from GI infection to Parkinson’s disease
BioCentury | Jan 18, 2018
Emerging Company Profile
Computing brain entry
How 1st Biotherapeutics is applying computational tools to CNS drug discovery
Items per page:
1 - 10 of 21